These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 16387281

  • 1. When will the genomics investment pay off for antibacterial discovery?
    Mills SD.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1096-102. PubMed ID: 16387281
    [Abstract] [Full Text] [Related]

  • 2. Genomic approaches to antibacterial discovery.
    Payne DJ, Gwynn MN, Holmes DJ, Rosenberg M.
    Methods Mol Biol; 2004 Mar 30; 266():231-59. PubMed ID: 15148422
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL, Barrett JF.
    Biochem Pharmacol; 2006 Mar 30; 71(7):901-9. PubMed ID: 16494849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P.
    Cancer Chemother Pharmacol; 2003 Jul 30; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [Abstract] [Full Text] [Related]

  • 10. Genetic strategies for antibacterial drug discovery.
    Miesel L, Greene J, Black TA.
    Nat Rev Genet; 2003 Jun 30; 4(6):442-56. PubMed ID: 12776214
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H, Sass P.
    Future Microbiol; 2010 Oct 30; 5(10):1553-79. PubMed ID: 21073314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H.
    Curr Opin Microbiol; 2004 Oct 30; 7(5):445-50. PubMed ID: 15451498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
    Vicente M, Hodgson J, Massidda O, Tonjum T, Henriques-Normark B, Ron EZ.
    FEMS Microbiol Rev; 2006 Nov 30; 30(6):841-52. PubMed ID: 17064283
    [Abstract] [Full Text] [Related]

  • 19. Delivering novel targets and antibiotics from genomics.
    Payne DJ, Holmes DJ, Rosenberg M.
    Curr Opin Investig Drugs; 2001 Aug 30; 2(8):1028-34. PubMed ID: 11892909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.